Running News and Research

RSS

Incyte declares closure of public offering shares

Incyte Corporation today announced the closing of its public offering of 20,700,000 shares of its common stock at a price to the public of $6.75 per share, which includes 2,700,000 shares sold upon exercise by the underwriters of their option to purchase additional shares.

1 Oct 2009

The American Legion urges Congress to pass VA budget without delay

The leader of The American Legion expressed disappointment today at the failure of Congress to okay an appropriations bill to fund the Department of Veterans Affairs during this new fiscal year, though a Continuing Resolution (CR) to provide additional funding for VA medical accounts was approved.

1 Oct 2009

Jindal to GOP: Time to say "here's what we're for"

In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..

1 Oct 2009

PSA test vital for assessing prostate cancer

When it comes to the prostate cancer, the disease known as the "silent killer" because it often exhibits no symptoms, to be forewarned is to be forearmed. It is the second leading cancer killer in men, just behind lung cancer. Every year, more than 218,000 men are diagnosed with prostate cancer in the United States, claiming about 28,000 lives.

1 Oct 2009

Portsys UK’s remote access appliance chosen to fight against pandemic threats

PortSys UK, a wholly owned subsidiary of Portcullis Systems, Inc. a US-based company and a Microsoft™ and HP™ partner offering solutions for secure remote access, announced today that Fareham College, a Further Education College offering a wide range of full and part time vocational and academic courses in South Hampshire, has chosen Portsys UK’s Secure Application Access Gateway appliance to bring remote access options to the college.

30 Sep 2009

Estrogen withdrawal may play a significant role in joint pain during breast cancer treatment

Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.

29 Sep 2009

Auxilium Pharmaceuticals declares pricing of common stock shares

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced the pricing of a public offering of 3 million shares of its common stock.

26 Sep 2009

Tenet Healthcare announces the completion of its registered public offering of convertible preferred stock

Tenet Healthcare Corporation (NYSE: THC) announced today that it has completed its previously announced registered public offering of 7.0% mandatory convertible preferred stock by selling 345,000 shares, including 45,000 shares sold pursuant to the underwriters' option to purchase additional shares, at a public offering price of $1,000 per share, for aggregate gross proceeds of $345 million.

25 Sep 2009

Living Proof Project showcases U.S. government's efforts to improve health around the world

The Bill & Melinda Gates Foundation today launched the Living Proof Project: U.S. Investments in Global Health are Working, a multi-year awareness campaign to highlight the extraordinary success of the U.S. government's efforts to improve health around the world.

24 Sep 2009

Lifeline Biotechnologies to establish demonstration site for its First Warning System

Lifeline Biotechnologies, Inc. today announced that it is preparing to establish a demonstration site for its First Warning System to be located in Reno, Nevada.

24 Sep 2009

SXC Health Solutions raises $203.3 million from public offering of its common shares

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC) announced today that it successfully completed its previously announced public offering of 5,175,000 of its common shares at a price to the public of $41.50 per share, which includes 675,000 shares sold pursuant to the exercise of the underwriters' over-allotment option.

24 Sep 2009

Obama addresses U.N. General Assembly, calls for 'new era of engagement'

In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).

24 Sep 2009

Insurers, GOP react to criticism of letters to seniors

Insurers and Republicans react to the Obama administration's criticism of letters about health care reform from insurance companies, including Humana, to seniors. The Associated Press reports: "Republican lawmakers rebuked the Obama administration Tuesday for telling health insurance companies to stop warning elderly customers about proposed health care legislation, which some equated to a gag order."

23 Sep 2009

Trial lawyers push back on medical malpractice reform

...

23 Sep 2009

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.

23 Sep 2009

Agilent Technologies and Applied Biosystems to co-market SureSelect system

Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform.

23 Sep 2009

NIH funding helps to boost sales of DNA sequencers

Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.

23 Sep 2009

Practice Fusion’s EHR offered to BioReference physicians

Practice Fusion Inc., the fastest growing electronic health record community for physicians in the United States, today announced a partnership with BioReference Laboratories, Inc. (NASDAQ:BRLI), the third largest full service laboratory in the country. The companies will collaborate to distribute Practice Fusion’s EHR to interested BioReference physicians and will integrate BioReference lab results into the Practice Fusion’s system.

23 Sep 2009

Pricing of secondary offering announced by Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) today announced the pricing of an underwritten secondary offering of 13,000,000 shares of its common stock at a price to the public of $9.85 per share.

23 Sep 2009

Oncology Metrics and Altos Solutions to merge

Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.

23 Sep 2009